In Vitro Diagnostics (IVD) Market to Surpass USD 157.9 Billion by 2031, Driven by 7.1% CAGR from 2025 to 2031 - QYResearch Analysis

LOS ANGELES, United States: The factual, unbiased, and thorough assessment of the global In Vitro Diagnostics (IVD) market presented in the report assures players of access to much-needed information and data to plan effective growth strategies. The report has made a brilliant attempt to provide a comprehensive research study on industry value chain, major companies, deployment models, and key opportunities, drivers, and restraints of the global In Vitro Diagnostics (IVD) market. It shows how the global In Vitro Diagnostics (IVD) market will advance or lack growth during each year of the forecast period. Readers are offered with detailed and near-accurate predictions of CAGR and market size of the global In Vitro Diagnostics (IVD) market and its important segments.

The global In Vitro Diagnostics (IVD) market was valued at US$ 98430 million in 2024 and is anticipated to reach US$ 157940 million by 2031, witnessing a CAGR of 7.1% during the forecast period 2025-2031.

Get PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.in/request-sample/service-software-global-in-vitro-diagnostics-ivd-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

The key players of In Vitro Diagnostics (IVD) include Roche, Siemens, Abbott and Danaher. The top four manufacturers hold approximately 42% of the global market share.

In terms of product type, Consumables is the largest segment, with a share of 87%. And in terms of application, Hospital has a share about 92percent.

Vendor Landscape Analysis

The competitive landscape of the global In Vitro Diagnostics (IVD) market is extensively researched in the report. The analysts have largely concentrated on company profiling of major players and also on competitive trends. All of the companies studied in the report are profiled on the basis of production, revenue, growth rate, markets served, areas served, market share, and market growth. The report will help readers to study significant changes in market competition, the level of competition, and factors impacting future market competition. It discusses important target market strategies that leading players are expected to adopt in future. In addition, it throws light on future plans of key players.

Details of In Vitro Diagnostics (IVD) Market Segmentation: -

Segment by Key Manufacturers:

Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
KHB
Daan Gene
Leadman
Zhongsheng
Bsbe
Maccura
Hitachi
Canon
Sysmex
Auto Bio
Mindray
Bgi
Wondfo

Segment by Type

Consumables
Equipment

Segment by Application

Hospital
Household

The report offers deep insights into leading segments of the global In Vitro Diagnostics (IVD) market and explains key factors helping them to collect a larger share. It provides accurate growth rate and market size achieved by each segment during the forecast period. This will help players to identify lucrative segments and plan out specific strategies to gain maximum profit from them. The report also includes sales growth, revenue, and price changes observed in important segments. Most importantly, the segmental analysis equips players with useful information and data to make the best of opportunities available in different segments.

Highlights of Report

(1) Buyers of the report will have access to unique information about top 10 players of the global In Vitro Diagnostics (IVD) market

(2) The report informs readers about future products and technologies to be introduced in the global In Vitro Diagnostics (IVD) market

(3) Readers are offered with comprehensive analysis on key revenue pockets of the global In Vitro Diagnostics (IVD) market

(4) The report provides details about long-term and short-term strategies adopted by major players of the global In Vitro Diagnostics (IVD) market

(5) The authors of the report have provided demand and growth trends of the global In Vitro Diagnostics (IVD) market and also its segments

(6) In the geographical analysis section, the report discusses about recent market developments in different regions and countries

The report can be used by players, stakeholders, and investors since it caters to all of them in a unique fashion. It offers special analysis on various competitive scenarios to help players to better compete in the global In Vitro Diagnostics (IVD) market. In the competitive analysis section, it provides a detailed list of important mergers and acquisitions, collaborations, and partnerships that key players have signed when operating in the global In Vitro Diagnostics (IVD) market. In the concluding part of the report, the analysts have provided powerful recommendations and suggestions to help players to ensure healthy growth in the global In Vitro Diagnostics (IVD) market.

For Further insights and Detailed Reports, Visit: https://www.qyresearch.in/pre-order-inquiry/service-software-global-in-vitro-diagnostics-ivd-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

Table of Content

1 In Vitro Diagnostics (IVD) Market Overview
1.1 Product Definition
1.2 In Vitro Diagnostics (IVD) by Type
1.2.1 Global In Vitro Diagnostics (IVD) Market Value by Type (2020-2031)
1.2.2 Consumables
1.2.3 Equipment
1.3 In Vitro Diagnostics (IVD) by Application
1.3.1 Global In Vitro Diagnostics (IVD) Market Value by Application 2020-2031)
1.3.2 Hospital
1.3.3 Household
1.4 Global In Vitro Diagnostics (IVD) Revenue (2020-2031)
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Key Insights
2.1 Key Emerging Trends
2.2 Key Developments - Mergers Acquisitions, New Product Launches, Collaborations, Partnerships and Joint Ventures
2.3 Latest Technological Advancements
2.4 Insights on Regulatory Scenarios
2.5 Porters Five Forces Analysis
3 Players Competitive Analysis
3.1 Global In Vitro Diagnostics (IVD) Revenue by Player (2020-2025)
3.2 In Vitro Diagnostics (IVD) Company Evaluation Quadrant
3.3 Industry Rank
3.3.1 Global Key Players of In Vitro Diagnostics (IVD), Industry Ranking, 2023 VS 2024
3.3.2 Global In Vitro Diagnostics (IVD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3.3 Global In Vitro Diagnostics (IVD) Market Concentration Rate
3.3.4 Global 5 and 10 Largest In Vitro Diagnostics (IVD) Players Market Share by Revenue
3.4 In Vitro Diagnostics (IVD) Market: Overall Company Footprint Analysis
3.4.1 In Vitro Diagnostics (IVD) Market: Region Footprint
3.4.2 In Vitro Diagnostics (IVD) Market: Company Product Type Footprint
3.4.3 In Vitro Diagnostics (IVD) Market: Company Product Application Footprint
3.4.4 Global Key Players of In Vitro Diagnostics (IVD), Date of Enter into This Industry
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
4 Players Profiles
4.1 Roche
4.1.1 Roche Company Details
4.1.2 Roche Business Overview
4.1.3 Roche In Vitro Diagnostics (IVD) Introduction
4.1.4 Roche Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.1.5 Roche Recent Development
4.2 Siemens
4.2.1 Siemens Company Details
4.2.2 Siemens Business Overview
4.2.3 Siemens In Vitro Diagnostics (IVD) Introduction
4.2.4 Siemens Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.2.5 Siemens Recent Development
4.3 Abbott
4.3.1 Abbott Company Details
4.3.2 Abbott Business Overview
4.3.3 Abbott In Vitro Diagnostics (IVD) Introduction
4.3.4 Abbott Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.3.5 Abbott Recent Development
4.4 Danaher
4.4.1 Danaher Company Details
4.4.2 Danaher Business Overview
4.4.3 Danaher In Vitro Diagnostics (IVD) Introduction
4.4.4 Danaher Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.4.5 Danaher Recent Development
4.5 Thermo Fisher
4.5.1 Thermo Fisher Company Details
4.5.2 Thermo Fisher Business Overview
4.5.3 Thermo Fisher In Vitro Diagnostics (IVD) Introduction
4.5.4 Thermo Fisher Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.5.5 Thermo Fisher Recent Development
4.6 BioMerieux
4.6.1 BioMerieux Company Details
4.6.2 BioMerieux Business Overview
4.6.3 BioMerieux In Vitro Diagnostics (IVD) Introduction
4.6.4 BioMerieux Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.6.5 BioMerieux Recent Development
4.7 Bio-Rad
4.7.1 Bio-Rad Company Details
4.7.2 Bio-Rad Business Overview
4.7.3 Bio-Rad In Vitro Diagnostics (IVD) Introduction
4.7.4 Bio-Rad Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.7.5 Bio-Rad Recent Development
4.8 BD
4.8.1 BD Company Details
4.8.2 BD Business Overview
4.8.3 BD In Vitro Diagnostics (IVD) Introduction
4.8.4 BD Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.8.5 BD Recent Development
4.9 KHB
4.9.1 KHB Company Details
4.9.2 KHB Business Overview
4.9.3 KHB In Vitro Diagnostics (IVD) Introduction
4.9.4 KHB Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.9.5 KHB Recent Development
4.10 Daan Gene
4.10.1 Daan Gene Company Details
4.10.2 Daan Gene Business Overview
4.10.3 Daan Gene In Vitro Diagnostics (IVD) Introduction
4.10.4 Daan Gene Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.10.5 Daan Gene Recent Development
4.11 Leadman
4.11.1 Leadman Company Details
4.11.2 Leadman Business Overview
4.11.3 Leadman In Vitro Diagnostics (IVD) Introduction
4.11.4 Leadman Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.11.5 Leadman Recent Development
4.12 Zhongsheng
4.12.1 Zhongsheng Company Details
4.12.2 Zhongsheng Business Overview
4.12.3 Zhongsheng In Vitro Diagnostics (IVD) Introduction
4.12.4 Zhongsheng Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.12.5 Zhongsheng Recent Development
4.13 Bsbe
4.13.1 Bsbe Company Details
4.13.2 Bsbe Business Overview
4.13.3 Bsbe In Vitro Diagnostics (IVD) Introduction
4.13.4 Bsbe Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.13.5 Bsbe Recent Development
4.14 Maccura
4.14.1 Maccura Company Details
4.14.2 Maccura Business Overview
4.14.3 Maccura In Vitro Diagnostics (IVD) Introduction
4.14.4 Maccura Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.14.5 Maccura Recent Development
4.15 Hitachi
4.15.1 Hitachi Company Details
4.15.2 Hitachi Business Overview
4.15.3 Hitachi In Vitro Diagnostics (IVD) Introduction
4.15.4 Hitachi Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.15.5 Hitachi Recent Development
4.16 Canon
4.16.1 Canon Company Details
4.16.2 Canon Business Overview
4.16.3 Canon In Vitro Diagnostics (IVD) Introduction
4.16.4 Canon Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.16.5 Canon Recent Development
4.17 Sysmex
4.17.1 Sysmex Company Details
4.17.2 Sysmex Business Overview
4.17.3 Sysmex In Vitro Diagnostics (IVD) Introduction
4.17.4 Sysmex Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.17.5 Sysmex Recent Development
4.18 Auto Bio
4.18.1 Auto Bio Company Details
4.18.2 Auto Bio Business Overview
4.18.3 Auto Bio In Vitro Diagnostics (IVD) Introduction
4.18.4 Auto Bio Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.18.5 Auto Bio Recent Development
4.19 Mindray
4.19.1 Mindray Company Details
4.19.2 Mindray Business Overview
4.19.3 Mindray In Vitro Diagnostics (IVD) Introduction
4.19.4 Mindray Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.19.5 Mindray Recent Development
4.20 Bgi
4.20.1 Bgi Company Details
4.20.2 Bgi Business Overview
4.20.3 Bgi In Vitro Diagnostics (IVD) Introduction
4.20.4 Bgi Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.20.5 Bgi Recent Development
4.21 Wondfo
4.21.1 Wondfo Company Details
4.21.2 Wondfo Business Overview
4.21.3 Wondfo In Vitro Diagnostics (IVD) Introduction
4.21.4 Wondfo Revenue in In Vitro Diagnostics (IVD) Business (2020-2025)
4.21.5 Wondfo Recent Development
5 Analysis by Region
5.1 Global In Vitro Diagnostics (IVD) Market Size by Region
5.1.1 Global In Vitro Diagnostics (IVD) Revenue by Region: 2020 VS 2024 VS 2031
5.1.2 Global In Vitro Diagnostics (IVD) Revenue by Region (2020-2025)
5.1.3 Global In Vitro Diagnostics (IVD) Revenue by Region (2026-2031)
5.1.4 Global In Vitro Diagnostics (IVD) Revenue Market Share by Region (2020-2031)
5.2 North America In Vitro Diagnostics (IVD) Revenue (2020-2031)
5.3 Europe In Vitro Diagnostics (IVD) Revenue (2020-2031)
5.4 Asia-Pacific In Vitro Diagnostics (IVD) Revenue (2020-2031)
5.5 South America In Vitro Diagnostics (IVD) Revenue (2020-2031)
5.6 Middle East & Africa In Vitro Diagnostics (IVD) Revenue (2020-2031)
6 Market Scenario by Region & Country
6.1 Global In Vitro Diagnostics (IVD) Revenue by Region & Country: 2020 Versus 2024 Versus 2031
6.2 Global In Vitro Diagnostics (IVD) Revenue by Region & Country (2020-2031)
6.3 North America In Vitro Diagnostics (IVD) Market Facts & Figures by Country
6.3.1 North America In Vitro Diagnostics (IVD) Revenue by Country: 2020 VS 2024 VS 2031
6.3.2 North America In Vitro Diagnostics (IVD) Revenue by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe In Vitro Diagnostics (IVD) Market Facts & Figures by Country
6.4.1 Europe In Vitro Diagnostics (IVD) Revenue by Country: 2020 VS 2024 VS 2031
6.4.2 Europe In Vitro Diagnostics (IVD) Revenue by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.5 Asia Pacific In Vitro Diagnostics (IVD) Market Facts & Figures by Region
6.5.1 Asia Pacific In Vitro Diagnostics (IVD) Market Size by Region: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific In Vitro Diagnostics (IVD) Revenue by Region (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 India
6.5.7 Australia
6.5.8 China Taiwan
6.5.9 Indonesia
6.5.10 Thailand
6.5.11 Malaysia
6.6 South America In Vitro Diagnostics (IVD) Market Facts & Figures by Country
6.6.1 South America In Vitro Diagnostics (IVD) Market Size by Country: 2020 VS 2024 VS 2031
6.6.2 South America In Vitro Diagnostics (IVD) Revenue by Country
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Argentina
6.7 Middle East and Africa In Vitro Diagnostics (IVD) Market Facts & Figures by Country
6.7.1 Middle East and Africa In Vitro Diagnostics (IVD) Market Size by Country: 2020 VS 2024 VS 2031
6.7.2 Middle East and Africa In Vitro Diagnostics (IVD) Revenue by Country
6.7.3 Turkey
6.7.4 Saudi Arabia
6.7.5 UAE
7 Segment by Type
7.1 Global In Vitro Diagnostics (IVD) Revenue by Type (2020-2025)
7.2 Global In Vitro Diagnostics (IVD) Revenue by Type (2026-2031)
7.3 Global In Vitro Diagnostics (IVD) Revenue Market Share by Type (2020-2031)
8 Segment by Application
8.1 Global In Vitro Diagnostics (IVD) Revenue by Application (2020-2025)
8.2 Global In Vitro Diagnostics (IVD) Revenue by Application (2026-2031)
8.3 Global In Vitro Diagnostics (IVD) Revenue Market Share by Application (2020-2031)
9 Industry Chain and Sales Channels Analysis
9.1 In Vitro Diagnostics (IVD) Industry Chain Analysis
9.2 In Vitro Diagnostics (IVD) Key Raw Materials
9.2.1 Key Raw Materials
9.2.2 Raw Materials Key Suppliers
9.3 In Vitro Diagnostics (IVD) Production Mode & Process
9.4 In Vitro Diagnostics (IVD) Sales and Marketing
9.4.1 In Vitro Diagnostics (IVD) Sales Channels
9.4.2 In Vitro Diagnostics (IVD) Distributors
9.5 In Vitro Diagnostics (IVD) Customers
10 Research Findings and Conclusion
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Author Details
11.3 Disclaimer

About US:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

Contact US

QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
Web - https://www.qyresearch.in
Tel: +91-8149736330
Email- ankit@qyresearch.com

This release was published on openPR.